Exact Sciences Corp (EXAS)
134.82
-3.89 -2.80%
NASDAQ
Feb 24, 20:00
USD
Exact Sciences Quarterly Actual Revenue
View 4,000+ financial data types
Browse...
View Full Chart
Quarterly Actual Revenue Chart
Historical Quarterly Actual Revenue Data
View and export this data going back to 2019.
Start your Free Trial
Export Data
Date Range:
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
View Quarterly Actual Revenue for EXAS
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
Start your free 7-Day Trial.
Start My Free Trial
No credit card required.
Already a subscriber? Sign in.
Advertisement
Quarterly Actual Revenue Benchmarks
Illumina Inc | Upgrade |
Natera Inc | Upgrade |
Guardant Health Inc | Upgrade |
Quarterly Actual Revenue Range, Past 5 Years
Minimum | Upgrade | Mar 2019 |
Maximum | Upgrade | Dec 2020 |
Average | Upgrade |
News
--Analyst Actions: UBS Adjusts Exact Sciences PT to $154 From $140, Maintains Neutral Rating
MT Newswires 02/18 11:24 ET
MT Newswires 02/18 11:24 ET
Viking Global initiates positions in General Electric, Disney, adds Microsoft and exits Comcast
SA Breaking News 02/17 12:59 ET
SA Breaking News 02/17 12:59 ET
--Analyst Actions: Cowen & Co Adjusts Exact Sciences PT to $180 From $150, Maintains Outperform Rating
MT Newswires 02/17 10:25 ET
MT Newswires 02/17 10:25 ET
Exact Sciences to Acquire Ashion Analytics from City of Hope Affiliate TGen; Terms Not Disclosed
MT Newswires 02/16 16:41 ET
MT Newswires 02/16 16:41 ET
Exact Sciences Swings to Q4 Net Loss of $2.79 a Share; Revenue Rises Ahead of Estimates
MT Newswires 02/16 16:28 ET
MT Newswires 02/16 16:28 ET
-- Earnings Flash (EXAS) EXACT SCIENCES Reports Q4 Revenue $466.3M, vs. Street Est of $447.1M
MT Newswires 02/16 16:06 ET
MT Newswires 02/16 16:06 ET
Advertisement